MRSA - Methicillin-resistant Staphylococcus aureus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MRSA - Methicillin-resistant Staphylococcus aureus

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: caly who wrote (168)	10/6/2014 1:46:09 PM
From: zen_lunatic420	Read Replies (1) of 191

Surprised no one posted this here yet, New Executive Actions to Combat Antibiotic Resistance and Protect Public Health: whitehouse.gov Let the stock picking begin! I once again submit my pick of Covalon (COV.v/CVALF), a small profitable Canadian company who licensed a dual antimicrobial dressings to Molnlycke Healthcare last November. Their shares are quite cheap right now and quite attractive IMO. I posted a bit of a DD summary on this board on I-Hub here: siliconinvestor.com Way more speculative and pricey, CTIX may have an effective antibiotic candidate in Phase II trials now, but I just don't play this speculative of stocks anymore, with a $300M market cap and no revenue.....it could well grow by multiples from here still; but also poses significant downside risks IMO: finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next